Questioning Authority: French Court Overturns Health Agency's Diabetes Guidelines, Citing Conflict Of Interest Rules

The French court's action may force the country's regulatory bodies to take a closer look at their links with the pharmaceutical industry and reflects further fall-out from the Mediator scandal.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet